Skip to main content
Erschienen in: Quality of Life Research 1/2011

01.02.2011

Solitary pulmonary nodules: consequences for patient quality of life

verfasst von: Irawati Lemonnier, Cédric Baumann, Damien Jolly, Patrick Arveux, Marie-Christine Woronoff-Lemsi, Michel Velten, Francis Guillemin

Erschienen in: Quality of Life Research | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim was to describe levels of health-related quality of life (HRQoL) and its determinants in patients with solitary pulmonary nodule (SPN) and to compare them with the French general population.

Methods

A prospective multicentre study of patients diagnosed with SPN, in northeastern regions of France, was carried out between 2002 and 2005. Six months after the end of diagnostic procedure, patients completed the SF-36 self-reported questionnaire (where 100 indicates high HRQoL). For a comparison, HRQoL data from a sample of the French general population collected by INSEE in 2002–2003 (n = 17,750).

Results

Among 171 participating patients, 39 had malignant nodules and had lesser mean scores on physical and emotional role, vitality and social functioning (6 to18 points) than those with nonmalignant nodule. Compared to the French general population, patients with SPN had lower scores, by 11–30 points, in all dimensions (P < 0.001). Older age and smoking history were associated with low HRQoL.

Conclusions

Six months after receiving a diagnosis of SPNs, whether malignant, patients have worse HRQoL compared to the French general population. It indicates areas where physicians can help patients coping with their disease.
Literatur
1.
Zurück zum Zitat Beigelman-Aubry, C., Hill, C., & Grenier, P. A. (2007). Management of an incidentally discovered pulmonary nodule. European Radiology, 17, 449–466.CrossRefPubMed Beigelman-Aubry, C., Hill, C., & Grenier, P. A. (2007). Management of an incidentally discovered pulmonary nodule. European Radiology, 17, 449–466.CrossRefPubMed
2.
Zurück zum Zitat Ost, D., & Fein, A. (2004). Management strategies for the solitary pulmonary nodule. Current Opinion in Pulmonary Medicine, 10(4), 272–278.CrossRefPubMed Ost, D., & Fein, A. (2004). Management strategies for the solitary pulmonary nodule. Current Opinion in Pulmonary Medicine, 10(4), 272–278.CrossRefPubMed
3.
Zurück zum Zitat Lillington, G. A. (1991). Management of solitary pulmonary nodules. Disease-a-Month, 37(5), 271–318.CrossRefPubMed Lillington, G. A. (1991). Management of solitary pulmonary nodules. Disease-a-Month, 37(5), 271–318.CrossRefPubMed
4.
Zurück zum Zitat Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51(1), 15–36.CrossRef Greenlee, R. T., Hill-Harmon, M. B., Murray, T., & Thun, M. (2001). Cancer statistics, 2001. CA: A Cancer Journal for Clinicians, 51(1), 15–36.CrossRef
5.
Zurück zum Zitat Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 52(1), 23–47.CrossRef Jemal, A., Thomas, A., Murray, T., & Thun, M. (2002). Cancer statistics, 2002. CA: A Cancer Journal for Clinicians, 52(1), 23–47.CrossRef
6.
Zurück zum Zitat Swanson, S. J., Jaklitsch, M. T., Mentzer, S. J., Bueno, R., Lukanich, J. M., & Sugarbaker, D. J. (1999). Management of the solitary pulmonary nodule: Role of thoracoscopy in diagnosis and therapy. Chest, 116(6 Suppl), 523S–524S.CrossRefPubMed Swanson, S. J., Jaklitsch, M. T., Mentzer, S. J., Bueno, R., Lukanich, J. M., & Sugarbaker, D. J. (1999). Management of the solitary pulmonary nodule: Role of thoracoscopy in diagnosis and therapy. Chest, 116(6 Suppl), 523S–524S.CrossRefPubMed
7.
Zurück zum Zitat Alzahouri, K., Velten, M., Arveux, P., Woronoff-Lemsi, M. C., Jolly, D., & Guillemin, F. (2008). Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: A multicentre study in 18 French districts. BMC Cancer, 8, 93.CrossRefPubMed Alzahouri, K., Velten, M., Arveux, P., Woronoff-Lemsi, M. C., Jolly, D., & Guillemin, F. (2008). Management of SPN in France. Pathways for definitive diagnosis of solitary pulmonary nodule: A multicentre study in 18 French districts. BMC Cancer, 8, 93.CrossRefPubMed
8.
Zurück zum Zitat Lillington, G. A. (1997). Management of solitary pulmonary nodules. How to decide when resection is required. Postgraduate Medicine, 101(3), 145–150. Lillington, G. A. (1997). Management of solitary pulmonary nodules. How to decide when resection is required. Postgraduate Medicine, 101(3), 145–150.
9.
Zurück zum Zitat Trunk, G., Gracey, D. R., & Byrd, R. B. (1974). The management and evaluation of the solitary pulmonary nodule. Chest, 66(3), 236–239.CrossRefPubMed Trunk, G., Gracey, D. R., & Byrd, R. B. (1974). The management and evaluation of the solitary pulmonary nodule. Chest, 66(3), 236–239.CrossRefPubMed
10.
Zurück zum Zitat Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123(1), 232–235.CrossRef Beijer, S., Kempen, G. I., Pijls-Johannesma, M. C., de Graeff, A., & Dagnelie, P. C. (2008). Determinants of overall quality of life in preterminal cancer patients. International Journal of Cancer, 123(1), 232–235.CrossRef
11.
Zurück zum Zitat Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43, 175–182.CrossRefPubMed Lheureux, M., Raherison, C., Vernejoux, J. M., Nguyen, L., Nocent, C., Tunon De Lara, M., et al. (2004). Quality of life in lung cancer: Does disclosure of the diagnosis have an impact? Lung Cancer, 43, 175–182.CrossRefPubMed
12.
Zurück zum Zitat Montazeri, A., Gillis, C. R., & McEwen, J. (1998). Quality of life in patients with lung cancer: A review of literature from 1970 to 1995. Chest, 113(2), 467–481.CrossRefPubMed Montazeri, A., Gillis, C. R., & McEwen, J. (1998). Quality of life in patients with lung cancer: A review of literature from 1970 to 1995. Chest, 113(2), 467–481.CrossRefPubMed
13.
Zurück zum Zitat Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12(2), 157–166.CrossRefPubMed Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2003). How quality of life data contribute to our understanding of cancer patients’ experiences? A study of patients with lung cancer. Quality of Life Research, 12(2), 157–166.CrossRefPubMed
14.
Zurück zum Zitat Efficace, F., Bottomley, A., Smit, E. F., Lianes, P., Legrand, C., Debruyne, C., et al. (2006). Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology, 17(11), 1698–1704.CrossRefPubMed Efficace, F., Bottomley, A., Smit, E. F., Lianes, P., Legrand, C., Debruyne, C., et al. (2006). Is a patient’s self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. Annals of Oncology, 17(11), 1698–1704.CrossRefPubMed
15.
Zurück zum Zitat Langendijk, H., Aaronson, N. K., de Jong, J. M., ten Velde, G. P., Muller, M. J., & Wouters, M. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy & Oncology, 55(1), 19–25.CrossRef Langendijk, H., Aaronson, N. K., de Jong, J. M., ten Velde, G. P., Muller, M. J., & Wouters, M. (2000). The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiotherapy & Oncology, 55(1), 19–25.CrossRef
16.
Zurück zum Zitat Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001). Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer, 31(2–3), 233–240.CrossRefPubMed Montazeri, A., Milroy, R., Hole, D., McEwen, J., & Gillis, C. R. (2001). Quality of life in lung cancer patients: As an important prognostic factor. Lung Cancer, 31(2–3), 233–240.CrossRefPubMed
17.
Zurück zum Zitat Testa, M. A., & Simonson, D. C. (1996). Assesment of quality-of-life outcomes. The New England Journal of Medicine, 334(13), 835–840.CrossRefPubMed Testa, M. A., & Simonson, D. C. (1996). Assesment of quality-of-life outcomes. The New England Journal of Medicine, 334(13), 835–840.CrossRefPubMed
18.
Zurück zum Zitat van Gerth, R. W. (2005). Assessment of quality of life: Adavantages and pitfals. Journal of Clinical and Experimental All Review, 5, 32–35.CrossRef van Gerth, R. W. (2005). Assessment of quality of life: Adavantages and pitfals. Journal of Clinical and Experimental All Review, 5, 32–35.CrossRef
19.
Zurück zum Zitat The WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159.CrossRef The WHOQOL Group. (1993). Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Quality of Life Research, 2(2), 153–159.CrossRef
20.
Zurück zum Zitat Brédart, A., & Dolbeault, S. (2005). Quality of life assessment in oncology: I. Definitions and objectives. Review of Francopoh Psycho-Oncologie, 1, 7–11.CrossRef Brédart, A., & Dolbeault, S. (2005). Quality of life assessment in oncology: I. Definitions and objectives. Review of Francopoh Psycho-Oncologie, 1, 7–11.CrossRef
21.
Zurück zum Zitat Lemonnier, I., Baumann, C., Jay, N., Alzahouri, K., Arveux, P., Jolly, D., et al. (2009). Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France. BMC Cancer, 9, 139.CrossRefPubMed Lemonnier, I., Baumann, C., Jay, N., Alzahouri, K., Arveux, P., Jolly, D., et al. (2009). Does the availability of positron emission tomography modify diagnostic strategies for solitary pulmonary nodules? An observational study in France. BMC Cancer, 9, 139.CrossRefPubMed
22.
Zurück zum Zitat L’INSEE. (2007). La France en faits et chiffres: Estimations de population au 1er janvier. L’INSEE. L’INSEE. (2007). La France en faits et chiffres: Estimations de population au 1er janvier. L’INSEE.
23.
Zurück zum Zitat INSEE. (2008). L’Enquete de Santé 2002–2003. INSEE. INSEE. (2008). L’Enquete de Santé 2002–2003. INSEE.
24.
Zurück zum Zitat Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305(6846), 160–164.CrossRefPubMed Brazier, J. E., Harper, R., Jones, N. M., O’Cathain, A., Thomas, K. J., Usherwood, T., et al. (1992). Validating the SF-36 health survey questionnaire: New outcome measure for primary care. British Medical Journal, 305(6846), 160–164.CrossRefPubMed
25.
Zurück zum Zitat Ware, J. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–783.CrossRefPubMed Ware, J. J., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–783.CrossRefPubMed
26.
Zurück zum Zitat Frost, M. H., Bonomi, A. E., Ferrans, C. E., Wong, G. Y., & Hays, R. D. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77(5), 488–494.CrossRefPubMed Frost, M. H., Bonomi, A. E., Ferrans, C. E., Wong, G. Y., & Hays, R. D. (2002). Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores. Mayo Clinic Proceedings, 77(5), 488–494.CrossRefPubMed
27.
Zurück zum Zitat Brunelli, A., Socci, L., Refai, M., Salati, M., Xiume, F., & Sabbatini, A. (2007). Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. The Annals of Thoracic Surgery, 84(2), 410–416.CrossRefPubMed Brunelli, A., Socci, L., Refai, M., Salati, M., Xiume, F., & Sabbatini, A. (2007). Quality of life before and after major lung resection for lung cancer: A prospective follow-up analysis. The Annals of Thoracic Surgery, 84(2), 410–416.CrossRefPubMed
28.
Zurück zum Zitat Handy, J. R., Jr., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., et al. (2002). What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest, 122(1), 21–30.CrossRefPubMed Handy, J. R., Jr., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., et al. (2002). What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. Chest, 122(1), 21–30.CrossRefPubMed
29.
Zurück zum Zitat Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.CrossRefPubMed Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Jr., Aaronson, N. K., Mosconi, P., et al. (2004). Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project. Quality of Life Research, 13(2), 283–298.CrossRefPubMed
30.
Zurück zum Zitat Lababede, O., Meziane, M. A., & Rice, T. W. (1999). TNM staging of lung cancer: A quick reference chart. Chest, 115(1), 233–235.CrossRefPubMed Lababede, O., Meziane, M. A., & Rice, T. W. (1999). TNM staging of lung cancer: A quick reference chart. Chest, 115(1), 233–235.CrossRefPubMed
31.
Zurück zum Zitat Perrotin, C., Lemeunier, P., Grahek, D., Molina, T., Petino, A., Alifano, M., et al. (2005). Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors. Revue des Maladies Respiratoires, 22(4), 579–585.PubMed Perrotin, C., Lemeunier, P., Grahek, D., Molina, T., Petino, A., Alifano, M., et al. (2005). Results of FDG-PET scanning in the pre-operative staging of broncho-pulmonary tumors. Revue des Maladies Respiratoires, 22(4), 579–585.PubMed
32.
Zurück zum Zitat Schiller, J. H. (2001). Current standards of care in small-cell and non-small-cell lung cancer. Oncology, 61(Suppl 1), 3–13.CrossRefPubMed Schiller, J. H. (2001). Current standards of care in small-cell and non-small-cell lung cancer. Oncology, 61(Suppl 1), 3–13.CrossRefPubMed
33.
Zurück zum Zitat King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.CrossRefPubMed King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.CrossRefPubMed
34.
Zurück zum Zitat Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.CrossRefPubMed Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.CrossRefPubMed
35.
Zurück zum Zitat Cooper, J. D. (2002). Management of the solitary pulmonary nodule: Directed resection. Seminars in Thoracic and Cardiovascular Surgery, 14(3), 286–291.PubMed Cooper, J. D. (2002). Management of the solitary pulmonary nodule: Directed resection. Seminars in Thoracic and Cardiovascular Surgery, 14(3), 286–291.PubMed
36.
Zurück zum Zitat Lejeune, C., Al Zahouri, K., Woronoff-Lemsi, M. C., Arveux, P., Bernard, A., Binquet, C., et al. (2005). Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. The European Journal of Health Economics, 6(3), 203–214.CrossRefPubMed Lejeune, C., Al Zahouri, K., Woronoff-Lemsi, M. C., Arveux, P., Bernard, A., Binquet, C., et al. (2005). Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule. The European Journal of Health Economics, 6(3), 203–214.CrossRefPubMed
37.
Zurück zum Zitat Tan, B. B., Flaherty, K. R., Kazerooni, E. A., & Iannettoni, M. D. (2003). The solitary pulmonary nodule. Chest, 123(1 Suppl), 89S–96S.CrossRefPubMed Tan, B. B., Flaherty, K. R., Kazerooni, E. A., & Iannettoni, M. D. (2003). The solitary pulmonary nodule. Chest, 123(1 Suppl), 89S–96S.CrossRefPubMed
Metadaten
Titel
Solitary pulmonary nodules: consequences for patient quality of life
verfasst von
Irawati Lemonnier
Cédric Baumann
Damien Jolly
Patrick Arveux
Marie-Christine Woronoff-Lemsi
Michel Velten
Francis Guillemin
Publikationsdatum
01.02.2011
Verlag
Springer Netherlands
Erschienen in
Quality of Life Research / Ausgabe 1/2011
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9719-0

Weitere Artikel der Ausgabe 1/2011

Quality of Life Research 1/2011 Zur Ausgabe